首页 › 肥胖症 › 南卡罗来纳州 › Charleston
Charleston SC 肥胖症临床试验
9项针对 肥胖症的研究正在 Charleston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Medical University Of South Carolina, Charleston
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Medical Uni of SC Charleston, Charleston
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- Coastal Pediatric Associates, Charleston
- Medical University of South Carolina Children Hospital - PIN, Charleston
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
招募中3 期
- Medical Uni of SC Charleston, Charleston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- Med. Uni. of SC Ashley River T, Charleston
Weight Loss and ExeRcise for Post-stroke Veterans
招募中
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
EMPOWER: Effects of Weight Loss and Exercise Post-stroke
招募中
- College of Health Professions, Charleston
Advanced Fibrosis Detection for MASLD in Primary Care
招募中
- Medical University of South Carolina, Charleston
Digital Wellness Nurse - FIT Families: Virtual Family Intervention for Adolescent Obesity
招募中
- MUSC - Division of Global and Community Health, Charleston
其他城市的 肥胖症试验
- Houston, TX43 项研究
- Chicago, IL41 项研究
- New York City, NY40 项研究
- San Antonio, TX40 项研究
- Washington, DC33 项研究
- Orlando, FL32 项研究
- Dallas, TX30 项研究
- Boston, MA28 项研究
- Las Vegas, NV27 项研究
- Miami, FL27 项研究
- Baltimore, MD26 项研究
- Jacksonville, FL25 项研究
Charleston的其他研究
- 抑郁症19 项研究
- 卒中18 项研究
- 心力衰竭18 项研究
- 非小细胞肺癌16 项研究
- 创伤后应激障碍16 项研究
- 心血管疾病15 项研究
- 前列腺癌15 项研究
- 癌症（所有类型）14 项研究
- 头颈鳞状细胞癌14 项研究
- 帕金森病13 项研究
- 间质性肺病13 项研究
- 乳腺癌12 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。